Table 6

Blood testing and bone density

All (382)Belfast (95)Brompton (99)Leicester (79)Manchester (′109)
Blood eosinophil count ×109/l (n)0.300.340.10.120.24p=0.001
(0.25–11.0)(0.19–0.72)(0.2–0.5)(0.35–0.58)(0.08–0.54)
(360)(94)(98)(72)(96)
Percentage sputum eosinophil count (n)3.06.03.451.0p=0.159
(0.25–11.25)(3–9)(0.07–17.12)(0–11.0)
(123)(31)(56)(36)
FeNO ppb (n)34.54030.534p=0.321
(16–65)(17–92)(14–65)(12–60)
(133)(57)(24)(52)
IgE kU/l (n)130113166.5126140p=0.831
(53.5–292)(60–256)(51.5–299.5)(50–335.5)(51–280)
(349)(93)(96)(77)(83)
IgG g/l (n)9.39.159.19.85p=0.052
(7.85–10.9)(7.9–10.0)(7.0–10.0)(8.1–11.77)
(195)(86)(63)(46)
IgA g/l (n)1.91.92.11.8p=0.275
(1.5–2.7)(1.48–2.72)(1.7–2.7)(1.21–2.58)
(195)(86)(63)(46)
IgM g/l (n)1.01.01.11.1p=0.588
(0.8–1.4)(0.7–1.4)(0.88–1.4)(0.72–1.42)
(195)(86)(63)(46)
Bone density (T scores) *(n)(169)(41)(70)(58)
L1–L4−0.64±1.42−0.81±1.15−0.54±1.34−0.67±1.67p=0.603
Femoral neck−0.26±1.20−0.22±0.84−0.07±1.28−0.61±1.19p=0.017
  • * 18 (10.6%) subjects had either a spinal or femoral neck bone density less than or equal to −2.5 (osteoporosis) and 58 (34.3%) subjects had a spinal or femoral neck bone density less than or equal to −1.0 (osteopenia).

  • Group data (mean±SD or median (range)) for all subjects are presented in column 2 followed by data for individual centres. Between-centre comparisons for continuous variables were made using one-way aanalysis of variance or Kruksal–Wallis test (for posthoc comparisons, see text) and for categorical variables using χ2 analysis.

  • Significance was taken as p<0.01.

  • FeNO, fractional exhaled nitric oxide; Ig, immunoglobulin.